Is hysterosalpingo-foam sonography the new gold standard for assessing tubal patency? A systematic review and meta-analysis
Reproductive BioMedicine Online · 2025-01 · 50 (1) · 104380
DOI: 10.1016/j.rbmo.2024.104380 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reproductive BioMedicine Online, 2025-01. Verfasst von Elisabeth Gerard Cassiman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Gynaecology, CHRU de Nancy, Université de Lorraine, Nancy, France. Hauptthemen laut MEDLINE: Hysterosalpingography, Fallopian Tubes, Fallopian Tube Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this study was to compare hysterosalpingo-foam sonography (HyFosy) with other tubal patency tests to analyse its efficacy, safety and tolerance. A systematic review and meta-analysis were performed following the Cochrane Collaboration and PRISMA guidelines by searching PubMed and the Cochrane Library using the term 'HyFosy'. In total, 20 studies, published from 2012 to January 2023, were included in this review. Information about the identification of tubal patency, agreement with laparoscopy, pain intensity, procedure failure, occurrence of pregnancy, side effects and treatment modalities was extracted. In 94% of patients, HyFosy had the same result as laparoscopy. No difference was found between HyFosy and hysterosalpingography (HSG) in terms of identification of tubal patency [total risk ratio (TRR) 0.98, 95% CI 0.88-1.10] and procedure failure (TRR 0.47, 95% CI 0.07-3.05). The visual analogue scale pain score was in favour of HyFosy (TRR 1.09, 95% CI 1.00-1.17); 95% of patients scored
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Gynaecology, CHRU de Nancy, Université de Lorraine, Nancy, France.
- Department of Gynaecological Surgery, CHRU de Nancy, Université de Lorraine, Nancy, France.
- Department of Medical Gynaecology, CHRU de Nancy, Université de Lorraine, Nancy, France; Department of Fertility Medicine, CHRU de Nancy, Université de Lorraine, Nancy, France.
- Department of Obstetrics and Fetal Medicine, CHRU de Nancy, Université de Lorraine, Nancy, France.
- Department of Fertility Medicine, CHRU de Nancy, Université de Lorraine, Nancy, France; INSERM U1256 NGERE, Université de Lorraine, Vandœuvre-lès-Nancy, France. Electronic address: m.agopiantz@chru-nancy.fr.
Zitieren
APA
Gerard Cassiman, E., Harter, S., Mougel, R., Mezan De Malartic, C., Bertholdt, C., Morel, O., & Agopiantz, M. (2025). Is hysterosalpingo-foam sonography the new gold standard for assessing tubal patency? A systematic review and meta-analysis. Reproductive BioMedicine Online, 50(1), 104380. https://doi.org/10.1016/j.rbmo.2024.104380
Vancouver
Gerard Cassiman E, Harter S, Mougel R, Mezan De Malartic C, Bertholdt C, Morel O, et al. Is hysterosalpingo-foam sonography the new gold standard for assessing tubal patency? A systematic review and meta-analysis. Reproductive BioMedicine Online. 2025;50(1):104380. doi:10.1016/j.rbmo.2024.104380
BibTeX
@article{GerardCassiman2025,
author = {Gerard Cassiman, Elisabeth and Harter, Sophie and Mougel, Romane and Mezan De Malartic, Cécile and Bertholdt, Charline and Morel, Olivier and Agopiantz, Mikaël},
title = {Is hysterosalpingo-foam sonography the new gold standard for assessing tubal patency? A systematic review and meta-analysis},
journal = {Reproductive BioMedicine Online},
year = {2025},
volume = {50},
number = {1},
pages = {104380},
doi = {10.1016/j.rbmo.2024.104380}
}
EUVIMED